title: Sugammadex antagonising rocuronium in three patients with liver dysfunction undergoing transjugular intrahepatic portosystemic shunt.
authors.forename: C
authors.initials: C
authors.lastname: Batistaki
authors.forename: P
authors.initials: P
authors.lastname: Matsota
authors.forename: K
authors.initials: K
authors.lastname: Kalimeris
authors.forename: E
authors.initials: E
authors.lastname: Brountzos
authors.forename: G
authors.initials: G
authors.lastname: Kostopanagiotou
mesh_terms: D000328:Adult; D000732:Androstanols / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000762:Anesthesia Recovery Period; D006502:Budd-Chiari Syndrome / Q000150:complications; D005260:Female; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D008107:Liver Diseases / Q000150:complications* / Q000378:metabolism; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D016343:Monitoring, Intraoperative; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors* / Q000378:metabolism; D019168:Portasystemic Shunt, Transjugular Intrahepatic / Q000379:methods*; D000077123:Rocuronium; D000077122:Sugammadex; D047408:gamma-Cyclodextrins
chemical_list: D000732:Androstanols; D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins; D000077122:Sugammadex; D000077123:Rocuronium